Achieve Life Sciences ACHV
NASDAQ ACHV
$6.51 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Achieve Life Sciences (ACHV) Research & Development (2010 - 2026)

Updated

Achieve Life Sciences' Research & Development came in at $3.39 million for Q2 2026, down 49.5% from $6.71 million a year earlier but up 13.9% from the prior quarter.

Analysis

Achieve Life Sciences (ACHV) Research & Development (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Achieve Life Sciences reported Research & Development of $15.53 million, down 45.9% year-over-year; for FY2025, it was $22.96 million, up 0.6% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of 27.3% (FY2020 to FY2025).
  • Going back by year, Research & Development was $22.82 million in FY2024 (+44.3%), $15.81 million in FY2023 (-47.4%), $30.08 million in FY2022 (+25.5%) and $23.97 million in FY2021 (+248.2%).
  • The five-year range for quarterly Research & Development is $2.11 million (Q4 2023) to $9.87 million (Q3 2022).
  • Year-over-year, Research & Development has declined for four consecutive quarters, with growth averaging 44.7% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2024 (growth of 245.1%), and the weakest in Q4 2023 (a decline of 75.5%).
  • Business Quant data shows ACHV's Research & Development at $2.98 million (Q1 2026), $3.84 million (Q4 2025) and $5.32 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 3.65 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.34 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.05 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 1.76 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.81 Bn
10 Achieve Life Sciences 612.49 Mn 425.19 Mn - 3.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.39 Mn
Mar 31, 2026 2.98 Mn
Dec 31, 2025 3.84 Mn
Sep 30, 2025 5.32 Mn
Jun 30, 2025 6.71 Mn
Mar 31, 2025 7.10 Mn
Dec 31, 2024 7.30 Mn
Sep 30, 2024 7.61 Mn
Jun 30, 2024 5.11 Mn
Mar 31, 2024 2.80 Mn
Dec 31, 2023 2.11 Mn
Sep 30, 2023 3.58 Mn
Jun 30, 2023 4.59 Mn
Mar 31, 2023 5.53 Mn
Dec 31, 2022 8.61 Mn
Sep 30, 2022 9.87 Mn
Jun 30, 2022 7.21 Mn
Mar 31, 2022 4.39 Mn
Dec 31, 2021 4.51 Mn
Sep 30, 2021 4.59 Mn
API Access

Achieve Life Sciences Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ACHV&period=max&api_key=YOUR_API_KEY